These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 22451895)
1. Inter-chain acyl transfer reaction in a peptide six-helical bundle: a chemical method for regulating the interaction between peptides or proteins. Bai Y; Xue H; Ling Y; Cheng M; Cai L; Liu K Chem Commun (Camb); 2012 May; 48(36):4320-2. PubMed ID: 22451895 [TBL] [Abstract][Full Text] [Related]
2. Heteromeric assembled polypeptidic artificial hydrolases with a six-helical bundle scaffold. Bai Y; Ling Y; Shi W; Cai L; Jia Q; Jiang S; Liu K Chembiochem; 2011 Nov; 12(17):2647-58. PubMed ID: 21957084 [TBL] [Abstract][Full Text] [Related]
3. A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide. Xu W; Taylor JW Chem Biol Drug Des; 2007 Oct; 70(4):319-28. PubMed ID: 17937777 [TBL] [Abstract][Full Text] [Related]
4. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation. Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536 [TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41. Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393 [TBL] [Abstract][Full Text] [Related]
6. On resin side-chain cyclization of complex peptides using CuAAC. Ingale S; Dawson PE Org Lett; 2011 Jun; 13(11):2822-5. PubMed ID: 21553819 [TBL] [Abstract][Full Text] [Related]
7. Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity. Ryu JR; Jin BS; Suh MJ; Yoo YS; Yoon SH; Woo ER; Yu YG Biochem Biophys Res Commun; 1999 Nov; 265(3):625-9. PubMed ID: 10600471 [TBL] [Abstract][Full Text] [Related]
8. Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34. Wang LX; Song H; Liu S; Lu H; Jiang S; Ni J; Li H Chembiochem; 2005 Jun; 6(6):1068-74. PubMed ID: 15883971 [TBL] [Abstract][Full Text] [Related]
9. High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41. Jin BS; Lee WK; Ahn K; Lee MK; Yu YG J Biomol Screen; 2005 Feb; 10(1):13-9. PubMed ID: 15695339 [TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV. Gustchina E; Hummer G; Bewley CA; Clore GM J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842 [TBL] [Abstract][Full Text] [Related]
11. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors. Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018 [TBL] [Abstract][Full Text] [Related]
12. Expression and biochemical analysis of the entire HIV-2 gp41 ectodomain: determinants of stability map to N- and C-terminal sequences outside the 6-helix bundle core. Lay CS; Wilson KA; Kobe B; Kemp BE; Drummer HE; Poumbourios P FEBS Lett; 2004 Jun; 567(2-3):183-8. PubMed ID: 15178320 [TBL] [Abstract][Full Text] [Related]
13. Development of a FRET assay for monitoring of HIV gp41 core disruption. Xu Y; Hixon MS; Dawson PE; Janda KD J Org Chem; 2007 Aug; 72(18):6700-7. PubMed ID: 17685571 [TBL] [Abstract][Full Text] [Related]
14. Calmodulin binding properties of peptide analogues and fragments of the calmodulin-binding domain of simian immunodeficiency virus transmembrane glycoprotein 41. Yuan T; Tencza S; Mietzner TA; Montelaro RC; Vogel HJ Biopolymers; 2001 Jan; 58(1):50-62. PubMed ID: 11072229 [TBL] [Abstract][Full Text] [Related]
15. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41. Fujii G; Horvath S; Woodward S; Eiserling F; Eisenberg D Protein Sci; 1992 Nov; 1(11):1454-64. PubMed ID: 1303764 [TBL] [Abstract][Full Text] [Related]
16. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations. Kanyalkar M; Srivastava S; Saran A; Coutinho E J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441 [TBL] [Abstract][Full Text] [Related]
17. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Joshi SB; Dutch RE; Lamb RA Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252 [TBL] [Abstract][Full Text] [Related]
18. [Interaction of peptides of human immunodeficiency viral proteins with continuous cell lines of varying origin]. Khromykh LM; Skliarov LIu; Sbitneva IN; Kopina NA; Zaĭtseva MB; Kazanskiĭ DB Mol Biol (Mosk); 1998; 32(5):863-8. PubMed ID: 9914974 [No Abstract] [Full Text] [Related]
19. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41. Gallo SA; Clore GM; Louis JM; Bewley CA; Blumenthal R Biochemistry; 2004 Jun; 43(25):8230-3. PubMed ID: 15209519 [TBL] [Abstract][Full Text] [Related]
20. Coiled-coil surface presentation: an efficient HIV gp41 binding interface mimic. Schnarr NA; Kennan AJ J Am Chem Soc; 2004 Aug; 126(33):10260-1. PubMed ID: 15315435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]